Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study.

Biundo R, Weis L, Bostantjopoulou S, Stefanova E, Falup-Pecurariu C, Kramberger MG, Geurtsen GJ, Antonini A, Weintraub D, Aarsland D.

J Neural Transm (Vienna). 2016 Apr;123(4):431-8. doi: 10.1007/s00702-016-1517-6. Epub 2016 Feb 6.

2.

Neuronal epigenetics and the aging synapse.

Azpurua J, Eaton BA.

Front Cell Neurosci. 2015 May 27;9:208. doi: 10.3389/fncel.2015.00208. eCollection 2015. Review.

3.

Predictors of cognitive impairment in an early stage Parkinson's disease cohort.

Hu MT, Szewczyk-Królikowski K, Tomlinson P, Nithi K, Rolinski M, Murray C, Talbot K, Ebmeier KP, Mackay CE, Ben-Shlomo Y.

Mov Disord. 2014 Mar;29(3):351-9. doi: 10.1002/mds.25748. Epub 2014 Jan 6.

4.

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.

Irwin DJ, Lee VM, Trojanowski JQ.

Nat Rev Neurosci. 2013 Sep;14(9):626-36. doi: 10.1038/nrn3549. Epub 2013 Jul 31. Review.

5.

Behavioral disturbances in Parkinson's disease.

Anderson KE.

Dialogues Clin Neurosci. 2004 Sep;6(3):323-32.

6.

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Rodriguez-Oroz MC, Tröster AI, Weintraub D.

Mov Disord. 2011 Aug 15;26(10):1814-24. doi: 10.1002/mds.23823. Epub 2011 Jun 9. Review.

7.

Familial associations of Alzheimer disease and essential tremor with Parkinson disease.

Costello S, Bordelon Y, Bronstein J, Ritz B.

Eur J Neurol. 2010 Jun 1;17(6):871-8. doi: 10.1111/j.1468-1331.2010.02974.x. Epub 2010 Mar 17.

8.

Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics.

Sollinger AB, Goldstein FC, Lah JJ, Levey AI, Factor SA.

Parkinsonism Relat Disord. 2010 Mar;16(3):177-80. doi: 10.1016/j.parkreldis.2009.11.002. Epub 2009 Nov 25.

9.

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.

Uc EY, McDermott MP, Marder KS, Anderson SW, Litvan I, Como PG, Auinger P, Chou KL, Growdon JC; Parkinson Study Group DATATOP Investigators..

Neurology. 2009 Nov 3;73(18):1469-77. doi: 10.1212/WNL.0b013e3181bf992f.

10.

Rivastigmine for the treatment of dementia associated with Parkinson's disease.

Reingold JL, Morgan JC, Sethi KD.

Neuropsychiatr Dis Treat. 2007 Dec;3(6):775-83.

11.

Diagnosis and management of Parkinson's disease dementia.

Poewe W, Gauthier S, Aarsland D, Leverenz JB, Barone P, Weintraub D, Tolosa E, Dubois B.

Int J Clin Pract. 2008 Oct;62(10):1581-7. doi: 10.1111/j.1742-1241.2008.01869.x. Review.

12.

Depression in Parkinson's disease: health risks, etiology, and treatment options.

Frisina PG, Borod JC, Foldi NS, Tenenbaum HR.

Neuropsychiatr Dis Treat. 2008 Feb;4(1):81-91.

13.

Mild cognitive impairment in Parkinson's disease: the challenge and the promise.

Fernandez HH, Crucian GP, Okun MS, Price CC, Bowers D.

Neuropsychiatr Dis Treat. 2005 Mar;1(1):37-50.

14.

Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies.

Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, McKeith IG.

J Neurol Neurosurg Psychiatry. 2006 May;77(5):585-9.

15.

Cholinesterase inhibitors: drugs looking for a disease?

Maggini M, Vanacore N, Raschetti R.

PLoS Med. 2006 Apr;3(4):e140. Epub 2006 Apr 11. Review. No abstract available.

16.

Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.

Ravina B, Putt M, Siderowf A, Farrar JT, Gillespie M, Crawley A, Fernandez HH, Trieschmann MM, Reichwein S, Simuni T.

J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):934-9.

17.

Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease.

Hamada K, Hirayama M, Watanabe H, Kobayashi R, Ito H, Ieda T, Koike Y, Sobue G.

J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):423-6.

Supplemental Content

Support Center